Protein (1)
Launched (1)
Human (1)
His Tag & Avi Tag (1)
Biotin-labeled (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
HL2-H82E3 | HEK293 | Biotinylated Human HLA-A*02:01&B2M&HER2 (LIAHNQVRQV) Complex Protein (Monomer, MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NC-318 | NC-318; 5G-12 | Phase 2 Clinical | Yale School Of Medicine | Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Cholangiocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| DS-1501 | DS-1501 | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| PYX-106 | PYX-106; BSI-060T | Phase 1 Clinical | Boaoxin Biotechnology(Nanjing) Co Ltd | Solid tumours; Neoplasm Metastasis | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



